Results 1 to 10 of about 42,441 (299)

Left Ventricular Assist Devices [PDF]

open access: yesJournal of Education and Teaching in Emergency Medicine, 2017
Audience: The audience for this classic team-based learning (cTBL) session is emergency medicine residents, faculty, and students; although this topic is applicable to internal medicine and family medicine residents. Introduction: A left ventricular
Khuansiri Narajeenron   +2 more
doaj   +4 more sources

Structural Heart Interventions in Patients with Left Ventricular Assist Devices [PDF]

open access: yesReviews in Cardiovascular Medicine
Left ventricular assist devices (LVADs) have changed the landscape for patients with advanced heart failure (HF). With advances in pump design and management, patients with LVADs are living longer with improved quality of life despite having more ...
Puvi Seshiah   +7 more
doaj   +2 more sources

Intensive care experiences of patients with implanted left ventricular assist devices: a qualitative study [PDF]

open access: yesBMC Cardiovascular Disorders
Background Patients with left ventricular assist device implants experience unique physical, emotional, and psychosocial experiences during their intensive care unit period.
Nihal Celikturk Doruker
doaj   +2 more sources

Iron Deficiency in Patients with Left Ventricular Assist Devices [PDF]

open access: yesCardiac Failure Review
Iron deficiency is a common and independent predictor of adverse outcomes in patients with heart failure. The implications of iron deficiency in patients implanted with a left ventricular assist device (LVAD) are less established. This review recaps data
William Herrik Nielsen, Finn Gustafsson
doaj   +2 more sources

Biosensors with left ventricular assist devices. [PDF]

open access: yesHeart Fail Rev
AbstractHeart failure imposes a significant global health burden, standing as a primary contributor to mortality. Various indicators and physiological shifts within the body may hint at distinct cardiac conditions. Specific biosensors have the capability to identify these changes.
Abbassy M   +8 more
europepmc   +3 more sources

Aortic valve disorders and left ventricular assist devices

open access: yesFrontiers in Cardiovascular Medicine, 2023
Aortic valve disorders are important considerations in advanced heart failure patients being evaluated for left ventricular assist devices (LVAD) and those on LVAD support. Aortic insufficiency (AI) can be present prior to LVAD implantation or develop de
Deepak Acharya   +9 more
doaj   +1 more source

Left ventricular assist devices [PDF]

open access: yesJournal of the Intensive Care Society, 2020
Background There is a growing population of patients in the UK with advanced heart failure who are receiving a left ventricular assist device (LVAD) as a bridge to transplant. This is due to the plateauing number of heart transplantations and the increasing evidence of the effectiveness of these devices.
openaire   +2 more sources

Left ventricular assist devices: a kidney’s perspective [PDF]

open access: yesHeart Failure Reviews, 2015
The left ventricular assist device (LVAD) has become an established treatment option for patients with refractory heart failure. Many of these patients experience chronic kidney disease (CKD) due to chronic cardiorenal syndrome type II, which is often alleviated quickly following LVAD implantation.
Tromp, T R, de Jonge, N, Joles, J A
openaire   +3 more sources

Practice Issues for Evaluation and Management of the Suicidal Left Ventricular Assist Device Patient [PDF]

open access: yes, 2020
There is a high prevalence of depression among left ventricular assist device patients, who present with an increased risk of suicidality given access to means via the device either with nonadherence or disconnection.
Chernyak, Yelena   +3 more
core   +1 more source

Percutaneous left ventricular assist devices in refractory cardiac arrest: The role of chest compressions

open access: yesResuscitation Plus, 2023
Background: Recent studies describe an emerging role for percutaneous left ventricular assist devices such as Impella CP® as rescue therapy for refractory cardiac arrest.
Adam L. Gottula   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy